BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38492089)

  • 1. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment.
    Zhang X; Wang H; Zhang Y; Wang X
    Clin Exp Med; 2024 Mar; 24(1):54. PubMed ID: 38492089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the DNA methylome in chronic lymphocytic leukemia.
    Cahill N; Rosenquist R
    Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in chronic lymphocytic leukemia.
    Raval A; Byrd JC; Plass C
    Semin Oncol; 2006 Apr; 33(2):157-66. PubMed ID: 16616062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
    Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
    Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL.
    Pastore A; Gaiti F; Lu SX; Brand RM; Kulm S; Chaligne R; Gu H; Huang KY; Stamenova EK; Béguelin W; Jiang Y; Schulman RC; Kim KT; Alonso A; Allan JN; Furman RR; Gnirke A; Wu CJ; Melnick AM; Meissner A; Bernstein BE; Abdel-Wahab O; Landau DA
    Nat Commun; 2019 Apr; 10(1):1874. PubMed ID: 31015400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
    Kulis M; Martin-Subero JI
    Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
    Chen SS; Raval A; Johnson AJ; Hertlein E; Liu TH; Jin VX; Sherman MH; Liu SJ; Dawson DW; Williams KE; Lanasa M; Liyanarachchi S; Lin TS; Marcucci G; Pekarsky Y; Davuluri R; Croce CM; Guttridge DC; Teitell MA; Byrd JC; Plass C
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13433-8. PubMed ID: 19666576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age.
    Nannini DR; Cortese R; Egwom P; Palaniyandi S; Hildebrandt GC
    Clin Epigenetics; 2023 May; 15(1):81. PubMed ID: 37165442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and molecular biology of chronic lymphocytic leukemia.
    Carney DA; Wierda WG
    Curr Treat Options Oncol; 2005 May; 6(3):215-25. PubMed ID: 15869733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
    Giacopelli B; Zhao Q; Ruppert AS; Agyeman A; Weigel C; Wu YZ; Gerber MM; Rabe KG; Larson MC; Lu J; Blachly JS; Rogers KA; Wierda WG; Brown JR; Rai KR; Keating M; Rassenti LZ; Kipps TJ; Zenz T; Shanafelt TD; Kay NE; Abruzzo LV; Coombes KR; Woyach JA; Byrd JC; Oakes CC
    Blood; 2019 Aug; 134(8):688-698. PubMed ID: 31292113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
    Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
    Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
    Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
    Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
    Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
    J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
    Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
    Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.